entertainment -WSS

entertainment

author：focus 2025-09-27 22:05:52 - browse：779

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed.

In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease. Early data had showed the drug cut protein levels in the urine, a biomarker of kidney function, by half after nine months. That convinced regulators to give Filspari accelerated approval in February, pending full results using a more direct measure of kidney function.

The new data, after 24 months, showed that patients who received Filspari declined less quickly than those in the control group. But the results just missed statistical significance, with a P value of 0.058.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： New warning issued for rebooking air travel after delays, cancellations

WSS

Resistance to cancer drugs: A new genetic explanation

Mindstrong's demise and the future of mental health care

'Reaching a detente': STAT's Helen Branswell on covering Covid

Why the Crimean Bridge is key to Russia's war in Ukraine

FDA advisers vote against ALS treatment from BrainStorm

Data show record exodus of life scientists from academia

hotspot

entertainment

Wikipedia

Heart attack and stroke risk calculators need revising

States increasingly look to regulate hospital facility fees

How to save PrEP access — and even expand it

India sets sights on home

Apple is now the first public company to be valued at $3 trillion

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Drug repurposing or repositioning? The language matters

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Hollywood unions extend contract negotiations for actors

Data show record exodus of life scientists from academia

focus

Intercept Pharmaceuticals sells itself for less than $1 billion

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Shingles, which affected Dianne Feinstein, is on the rise

WHO recommends dropping component of many flu vaccines

How dance can help health care workers heal from trauma

Paxlovid should be available without a positive Covid test

focus

hotspot

entertainment

entertainment